Schulz, C. and Spira, A. and Park, K. and Mazieres, J. and Vansteenkiste, J. and Ballinger, M. and Waterkamp, D. and Fehrenbacher, L. (2016) Efficacy, safety and predictive biomarker results from a randomized phase II study comparing atezolizumab vs docetaxel in patients with advanced NSCLC (POPLAR). ONCOLOGY RESEARCH AND TREATMENT, 39 (Suppl3). p. 104. ISSN 2296-5270, 2296-5262
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Petra Gürster |
| Date Deposited: | 27 Aug 2020 09:36 |
| Last Modified: | 27 Aug 2020 09:36 |
| URI: | https://pred.uni-regensburg.de/id/eprint/4177 |
Actions (login required)
 |
View Item |
